| Name | [1-[(2,6-difluorophenyl)methyl]-4-methylbenzimidazol-2-yl]methanol |
|---|
| Density | 1.29g/cm3 |
|---|---|
| Boiling Point | 470.8ºC at 760 mmHg |
| Molecular Formula | C16H14F2N2O |
| Molecular Weight | 288.29200 |
| Flash Point | 238.5ºC |
| Exact Mass | 288.10700 |
| PSA | 38.05000 |
| LogP | 3.16350 |
| Vapour Pressure | 1.15E-09mmHg at 25°C |
| Index of Refraction | 1.599 |
|
~98%
199594-81-5 |
| Literature: The United States of America as represented by the Department of Health and Human Services Patent: US6369235 B1, 2002 ; Location in patent: Example 40 ; |
|
~%
199594-81-5 |
| Literature: Roth, Thomas; Morningstar, Marshall L.; Boyer, Paul L.; Hughes, Stephen H.; Buckheit Jr., Robert W.; Michejda, Christopher J. Journal of Medicinal Chemistry, 1997 , vol. 40, # 26 p. 4199 - 4207 |
|
~%
199594-81-5 |
| Literature: Roth, Thomas; Morningstar, Marshall L.; Boyer, Paul L.; Hughes, Stephen H.; Buckheit Jr., Robert W.; Michejda, Christopher J. Journal of Medicinal Chemistry, 1997 , vol. 40, # 26 p. 4199 - 4207 |
|
~%
199594-81-5 |
| Literature: Roth, Thomas; Morningstar, Marshall L.; Boyer, Paul L.; Hughes, Stephen H.; Buckheit Jr., Robert W.; Michejda, Christopher J. Journal of Medicinal Chemistry, 1997 , vol. 40, # 26 p. 4199 - 4207 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |